Concepedia

Richa Shrivastava

RS

23

Publications

1.1K

Citations

16

H-Index

1996

Active since

Affiliations

Central Drug Research Institute(Current)

King George's Medical University

Indian Institute of Toxicology Research

Academy of Scientific and Innovative Research

Institute of Cytology and Preventive Oncology

Richa Shrivastava is an author at Central Drug Research Institute specializing in medicine, pharmacology, and immunology.

ORCID

Top concepts

Publications per year

1996–2020

23

Publications

23

Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin

Chakrapani Tripathi, Brij Nath Tewari, Ranjana Kanchan et al. · Oncotarget · 2014 · 216 citations · Full text

Suboptimal chlorine treatment of drinking water leads to selection of multidrug-resistant Pseudomonas aeruginosa

Richa Shrivastava, Raj K. Upreti, Saloni R. Jain et al. · Ecotoxicology and Environmental Safety · 2003 · 135 citations

, , +14

Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin.

Vinay Dwivedi, Richa Shrivastava, Showket Hussain et al. · PubMed · 2011 · 101 citations

, , +18

Gut microflora & toxic metals: chromium as a model.

Raj K. Upreti, Richa Shrivastava, U. C. Chaturvedi · PubMed · 2004 · 77 citations

, , +16

M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis

Richa Shrivastava, Mohammad Asif, Varsha Singh et al. · Cytokine · 2018 · 75 citations

, , +10

Rows per page

1–5 of 23